Rocca, V.; Blandino, G.; D’Antona, L.; Iuliano, R.; Di Agostino, S.
Li–Fraumeni Syndrome: Mutation of TP53 Is a Biomarker of Hereditary Predisposition to Tumor: New Insights and Advances in the Treatment. Cancers 2022, 14, 3664.
https://doi.org/10.3390/cancers14153664
AMA Style
Rocca V, Blandino G, D’Antona L, Iuliano R, Di Agostino S.
Li–Fraumeni Syndrome: Mutation of TP53 Is a Biomarker of Hereditary Predisposition to Tumor: New Insights and Advances in the Treatment. Cancers. 2022; 14(15):3664.
https://doi.org/10.3390/cancers14153664
Chicago/Turabian Style
Rocca, Valentina, Giovanni Blandino, Lucia D’Antona, Rodolfo Iuliano, and Silvia Di Agostino.
2022. "Li–Fraumeni Syndrome: Mutation of TP53 Is a Biomarker of Hereditary Predisposition to Tumor: New Insights and Advances in the Treatment" Cancers 14, no. 15: 3664.
https://doi.org/10.3390/cancers14153664
APA Style
Rocca, V., Blandino, G., D’Antona, L., Iuliano, R., & Di Agostino, S.
(2022). Li–Fraumeni Syndrome: Mutation of TP53 Is a Biomarker of Hereditary Predisposition to Tumor: New Insights and Advances in the Treatment. Cancers, 14(15), 3664.
https://doi.org/10.3390/cancers14153664